Biomarin Pharmaceutical’s Kyndrisa was not enough to convince the FDA of its efficacy

Kyndrisa

A drug for treating Duchene Muscular Dystrophy has been deemed unsatisfactory in action by the FDA. Both Parent and patient testimony about the changes they experienced after taking Biomarin Pharmaceutical Inc. Kyndrisa was not enough to convince the FDA advisory committee of its efficacy. A bench of outside advisors to the regulatory agency United States […]

Continue reading>

Beautycon Begins $99 Subscription Service

Beautycon Media has announced the launch of a $99 subscription service for a quarterly beauty box called Beautycon BFF. The four boxes that customers receive annually are themed around winter, spring, summer and fall. The contents are contributed by brands and selected by the celebrities chosen to speak at Beautycon festival sessions. Each box will also […]

Continue reading>
Page 3 of 5